Home › Funds › Frazier Life Sciences Management, L.P. › PVLA

Frazier Life Sciences Management, L.P. position in PVLA

PALVELLA THERAPEUTICS INC NEW COM · Health Care

Frazier Life Sciences Management, L.P. reported holding 882,400 shares of PVLA (PALVELLA THERAPEUTICS INC NEW COM) in its Q2 2026 13F filing — a position valued at US$134.8M, representing 2.94% of its reported portfolio and ranking #10 among its reported holdings. Frazier Life Sciences Management, L.P. has disclosed PVLA holdings in 7 of the last 7 reported quarters, going back to Q4 2024.

Latest position (Q2 2026)882.40K sh
Reported value held$134.85M
Portfolio Weight2.94%
First reportedQ4 2024
Last changeHold
Updated2026-10-24

Last updated: 2026-10-24 · Source: SEC EDGAR Form 13F-HR

How Frazier Life Sciences Management, L.P.'s PVLA position evolved

Frazier Life Sciences Management, L.P. first disclosed a stake in PVLA in Q4 2024 at 653,892 shares (US$7.8M). The position peaked in Q2 2026 at 882,400 shares, worth US$134.8M. Across 7 filings, Frazier Life Sciences Management, L.P. increased the stake 3 time(s), trimmed it 0 time(s) and left it unchanged 3 time(s). The most recent filing (Q2 2026) shows 882,400 shares valued at US$134.8M.

Quarter by quarter

QuarterSharesValueChange
Q4 2024 653.89K $7.85M New
Q1 2025 690.01K $19.31M Add
Q2 2025 722.40K $16.28M Add
Q3 2025 722.40K $45.29M Hold
Q4 2025 722.40K $75.61M Hold
Q1 2026 882.40K $109.99M Add
Q2 2026 882.40K $134.85M Hold

Dots on the line are colored by change type; missing quarters mean no position was reported.

About PVLA and 13F data

PVLA (PALVELLA THERAPEUTICS INC NEW COM) is a Health Care company. 90 other funds we track also report a position in PVLA — the largest reported positions include MONTANOVA CAPITAL, LLC (US$173.5M), First Light Asset Management, LLC (US$118.0M), BVF INC/IL (US$102.8M). Under SEC rules, institutional investment managers with over $100M in assets must file Form 13F within 45 days of each quarter-end, disclosing long positions in US-listed equities. The data excludes short positions, most options and foreign holdings, so treat it as a quarterly snapshot rather than a live position.

Other funds holding PVLA

All PVLA fund holders →

FAQ

How long has Frazier Life Sciences Management, L.P. held PVLA?

Frazier Life Sciences Management, L.P. has disclosed PVLA holdings in 7 of the last 7 reported quarters, going back to Q4 2024.

What is Frazier Life Sciences Management, L.P.'s current position in PVLA?

As of Q2 2026, Frazier Life Sciences Management, L.P. holds 882.40K shares of PVLA (PALVELLA THERAPEUTICS INC NEW COM), valued at $134.85M, representing 2.94% of its reported portfolio and ranking #10.

Has Frazier Life Sciences Management, L.P. been buying or selling PVLA?

In the latest 13F filing (Q2 2026), Frazier Life Sciences Management, L.P. held unchanged its position in PVLA. The position peaked in Q2 2026 at 882.40K shares.

Which other funds hold PVLA?

Other major institutional holders of PVLA include MONTANOVA CAPITAL, LLC, First Light Asset Management, LLC, BVF INC/IL, among 90 funds with disclosed positions.

Where does this data come from?

All figures are computed from SEC Form 13F quarterly filings, which institutional investment managers must file within 45 days of quarter end for long positions of $100,000 or more.